20000306
 Elan of Ireland To Buy Liposome For $575 Million   By By Stephen D. Moore, The Wall Street Journal,  Mar 7, 2000  Elan, which got its start developing improved versions of other companies' drugs, has pushed aggressively into cutting-edge research of its own in recent years by snapping up U.S. biotech companies and snagging marketing accords for promising medicines with partners on both sides of the Atlantic. Elan's shopping spree has included several opportunistic swoops, including the acquisition of Liposome, Princeton, N.J.   
